High-Risk, High-Stakes: Sector-by-Sector Excise Duty Landmines Awaiting US Companies in India

India's indirect tax environment is demanding for any foreign investor, but it does not punish all industries equally. Certain sectors carry a disproportionate share of excise duty complexity — a combination of legacy classification frameworks, frequent regulatory amendments, and heightened enforcement attention that creates fertile ground for costly errors. For US companies with Indian operations, understanding which industries carry the greatest regulatory exposure is not an academic exercise. It is a prerequisite for sound financial planning.

What follows is a sector-by-sector analysis of five industries where US-owned Indian entities consistently encounter the steepest excise and GST penalties, the most consequential classification mistakes, and the most aggressive audit scrutiny.

1. Pharmaceuticals: Classification Disputes at the Intersection of Science and Tax Policy

India's pharmaceutical sector operates under a GST rate structure that distinguishes between life-saving drugs, nutraceuticals, medical devices, and cosmetic or wellness products — categories that are scientifically adjacent but taxed at dramatically different rates. The 5% rate applicable to essential medicines sits alongside 12% and 18% rates for other health-related products, and the boundary between categories is neither self-evident nor stable.

Common classification mistakes: US pharmaceutical companies frequently misclassify combination products that serve both therapeutic and cosmetic functions. A product marketed primarily as a supplement in the United States may be classified as a drug, a food product, or a cosmetic in India depending on its formulation and labeling — each with distinct GST implications. Errors in HSN (Harmonized System of Nomenclature) code assignment at the time of product registration cascade through every subsequent filing.

Recent regulatory shifts: The GST Council has revised pharmaceutical classifications multiple times since 2017, and the introduction of GST on COVID-related medical supplies created a period of significant rate volatility that many companies failed to track in real time. Retroactive classification corrections by Indian tax authorities have resulted in substantial demand notices for underpaid duty.

Audit red flags: Unusually high ITC claims relative to output tax liability, discrepancies between drug controller filings and GST product descriptions, and the use of composite supply structures to reduce effective tax rates are all triggers for pharmaceutical sector audits.

2. Alcohol and Spirits: A Regulatory Patchwork That Defies Uniformity

Alcohol for human consumption remains one of the few major product categories excluded from GST in India. Instead, it is governed by state-level excise regimes — meaning a US beverage company operating across multiple Indian states is effectively navigating dozens of distinct regulatory frameworks simultaneously.

Common classification mistakes: The distinction between country liquor, Indian-made foreign liquor (IMFL), and beer carries different duty implications in virtually every state. US companies accustomed to federal uniformity in alcohol regulation are frequently unprepared for the degree of state-level variation. Labeling requirements, permissible ingredients, and duty calculation methodologies differ not just in degree but in kind.

Recent regulatory shifts: Several states, including Andhra Pradesh and Tamil Nadu, have undertaken significant restructuring of their state excise policies in recent years, altering licensing fee structures, retail distribution models, and duty rates with limited advance notice. Companies that fail to monitor state-level legislative activity face sudden compliance gaps.

Audit red flags: Production volume discrepancies between manufacturing records and excise duty paid, cross-state movement of spirits without proper transit documentation, and royalty payments to US parent entities that affect the assessable value used for duty calculation are all high-priority audit targets in this sector.

3. Automobiles and Auto Components: The Compensation Cess Complication

The automotive sector occupies a unique position in India's GST architecture. Passenger vehicles attract a GST rate of 28% — already among the highest in the framework — supplemented by a compensation cess that varies by engine displacement and vehicle type, pushing the effective tax burden on premium vehicles well above 40%. For US automotive companies with Indian manufacturing or distribution operations, the interaction between GST, the compensation cess, and legacy central excise provisions creates layered compliance obligations.

Common classification mistakes: The distinction between a motor vehicle, a special purpose vehicle, and an automotive component is not always intuitive under Indian tariff headings. US companies have faced significant demand notices for classifying semi-knocked-down (SKD) kits at component-level duty rates when the assembled product attracts higher rates as a complete vehicle.

Recent regulatory shifts: The transition from the pre-GST CENVAT credit system to the current ITC framework left many automotive manufacturers with stranded credits that could not be carried forward under the transitional provisions. Companies that failed to file the requisite transitional credit declarations within the prescribed window permanently forfeited those balances.

Audit red flags: Transfer pricing on inter-company supply of components, warranty claim adjustments that reduce taxable value, and dealer discount structures that affect the transaction value for GST purposes are all subjects of active enforcement attention in the automotive sector.

4. Chemicals and Specialty Materials: HSN Code Precision in a Complex Taxonomy

The chemicals sector presents perhaps the most technically demanding classification environment in India's excise framework. With thousands of distinct chemical compounds, each potentially falling under multiple HSN headings depending on concentration, purity, intended use, and physical form, the margin for error is substantial — and the penalties for misclassification are not trivial.

Common classification mistakes: US specialty chemical companies frequently encounter disputes over whether a product is classified as a chemical intermediate, a finished product, or a mixture — each of which may carry different duty rates and different ITC eligibility profiles. The classification of chemical mixtures is particularly contentious, as Indian tax authorities have historically favored classifications that maximize duty liability.

Recent regulatory shifts: Environmental levies and the introduction of extended producer responsibility (EPR) obligations have added compliance dimensions to chemical sector operations that interact with, but are distinct from, GST obligations. Companies that treat these as separate compliance streams risk creating inconsistencies that surface during integrated audits.

Audit red flags: Significant divergence between the HSN codes used on import documentation and those used on domestic sale invoices, high volumes of job work transactions that obscure the effective manufacturing location, and R&D-related ITC claims that span both exempt and taxable activities.

5. Textiles: Rate Volatility and the Small Manufacturer Ecosystem

India's textile sector has been a recurring site of GST rate controversy. The sector's political sensitivity — it employs tens of millions of workers across a highly fragmented supply chain — means that rate revisions are frequent, often retroactive in their practical effect, and difficult to anticipate through standard regulatory monitoring.

Common classification mistakes: The distinction between yarn, fabric, and garments carries different rate implications, and the treatment of embellished, printed, or blended textiles has been the subject of repeated classification disputes. US fashion and apparel companies sourcing from Indian manufacturers have faced unexpected duty liability when their product specifications crossed classification thresholds.

Recent regulatory shifts: The January 2022 GST rate revision for textiles — which was partially reversed following industry pressure — illustrated how quickly the regulatory ground can shift in this sector. Companies that had structured their supply chains around the pre-revision rate structure faced immediate margin compression.

Audit red flags: Composition scheme usage by supplier entities that limits their ITC pass-through, job work arrangements that fragment the taxable supply chain, and export refund claims on textile products where the domestic and export product descriptions do not align precisely.

Building a Sector-Specific Compliance Defense

Across all five of these industries, the common thread is clear: India's excise and GST framework rewards specificity. Generic compliance programs designed for a US regulatory environment will not surface the sector-specific risks that Indian enforcement authorities are trained to pursue. US companies with Indian operations in any of these verticals should conduct periodic sector-specific compliance reviews — not simply annual return filings — to identify classification vulnerabilities, monitor regulatory amendments, and document the analytical basis for positions taken.

RajExcise Advisors specializes in sector-calibrated compliance reviews for US-owned Indian entities. If your operations fall within any of the industries outlined above, the time to assess your exposure is before the audit notice arrives — not after.